BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24054402)

  • 21. Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab.
    Maximiano Alonso C; Sánchez Ruiz AC; Cantos Sánchez de Ibargüen B; Méndez García M; Ronco IS; Provencio Pulla M
    Clin Transl Oncol; 2010 Oct; 12(10):701-3. PubMed ID: 20947485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.
    Huang YC; Liu CJ; Liu CY; Pai JT; Hong YC; Teng HW; Hsiao LT; Chao TC; Gau JP; Liu JH; Hsu HC; Chiou TJ; Chen PM; Yu YB; Tzeng CH
    Ann Hematol; 2011 Oct; 90(10):1145-51. PubMed ID: 21647583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study.
    Samochatova EV; Maschan AA; Shelikhova LN; Myakova NV; Belogurova MB; Khlebnikova OP; Shamardina AV; Ryskal OV; Roumiantseva JV; Konovalov DM; Dubrovina ME; Rumyantsev AG
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):395-401. PubMed ID: 23823112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].
    Hansen PB; Al-Farra G
    Ugeskr Laeger; 2010 Oct; 172(42):2907-8. PubMed ID: 21040668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?
    Cheah CY; Seymour JF
    Leuk Lymphoma; 2014 Mar; 55(3):471-3. PubMed ID: 23906017
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term results of rituximab-based salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma].
    Wang XX; Huang HQ; Xia ZJ; Lin XB; Cai QQ; Gao Y; Lin ZX; Lin TY; Jiang WQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):867-70. PubMed ID: 20423868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoport with a non-collapsible chamber as a replacement for an Ommaya reservoir in the treatment of leptomeningeal carcinomatosis.
    Gwak HS; Lee CH; Yang HS; Joo J; Shin SH; Yoo H; Lee JS; Lee SH
    Acta Neurochir (Wien); 2011 Oct; 153(10):1971-8; discussion 1978. PubMed ID: 21796363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of diffuse large B-cell lymphoma in a patient with ataxia telangiectasia using rituximab.
    Machida S; Tomizawa D; Tamaichi H; Okawa T; Endo A; Imai K; Nagasawa M; Morio T; Mizutani S; Takagi M
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):482-5. PubMed ID: 23389503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
    Huang HC; Cheng AL; Lin CW; Kuo SH
    Ann Hematol; 2013 Jul; 92(7):989-92. PubMed ID: 23242476
    [No Abstract]   [Full Text] [Related]  

  • 34. [Measurement of rituximab concentration in the cerebrospinal fluid in CNS lymphoma].
    Kikuchi A; Kawada H; Iwaki Y; Machida S; Tsuchiya T; Fukuda R; Hotta T
    Rinsho Ketsueki; 2004 Dec; 45(12):1255-7. PubMed ID: 15678918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
    Pfreundschuh M; Kuhnt E; Trümper L; Osterborg A; Trneny M; Shepherd L; Gill DS; Walewski J; Pettengell R; Jaeger U; Zinzani PL; Shpilberg O; Kvaloy S; de Nully Brown P; Stahel R; Milpied N; López-Guillermo A; Poeschel V; Grass S; Loeffler M; Murawski N;
    Lancet Oncol; 2011 Oct; 12(11):1013-22. PubMed ID: 21940214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Late-onset neutropenia following rituximab therapy as a treatment of diffuse large B-cell lymphoma: a single institution study].
    Kim M; Lee JK; Hong YJ; Hong SI; Kang HJ; Chang YH
    Korean J Lab Med; 2010 Dec; 30(6):575-9. PubMed ID: 21157141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute lung injury in a patient with concurrent diffuse large B-cell lymphoma and myelodysplastic syndrome].
    Tokuyama T; Muta T; Yasunaga M; Nakanishi H; Ueda Y; Fujisaki T
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1733-7. PubMed ID: 21996978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report.
    Meuleman N; Ahmad I; Duvillier H; Lemort M; Bennani J; Martiat M; Lagneaux L; Bron D
    Eur J Haematol; 2006 Dec; 77(6):523-6. PubMed ID: 17042768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diffue large B-cell lymphoma in a child treated by rituximab complicated with chemotherapy].
    Chang J; Wang LJ; Wang LZ; Zhang YT; Zhong XD
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):387-8. PubMed ID: 22613114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.